Cisplatin-ineligible and chemotherapy-ineligible patients should be the focus of new drug development in patients with advanced bladder cancer. (Q48383536)
Jump to navigation
Jump to search
scientific article published on 14 November 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Cisplatin-ineligible and chemotherapy-ineligible patients should be the focus of new drug development in patients with advanced bladder cancer. |
scientific article published on 14 November 2013 |
Statements
1 reference
Cisplatin-ineligible and chemotherapy-ineligible patients should be the focus of new drug development in patients with advanced bladder cancer. (English)
1 reference
1 reference
Guru Sonpavde
1 reference
Matthew D Galsky
1 reference
Guoqing J Chen
1 reference
14 November 2013
1 reference
12
1 reference
2
1 reference
71-73
1 reference